mobocertinib,cln-081,amivantamab
takeda,tahio oncology,Cullinan Oncology,genmab,janssen
['mobocertinib']
good call from tahio on $cgem cln-081, 3wks ahead of asco, clear edge on safety (very few gr3+) vs amivantamab &amp; mobocertinib, with equivalent efficacy
Biotellytics / https://t.co/37itIfRolp = business intel service on listed European Bios / Views=mine only, RT-like=/=endorse, no advice. 16y in Tech (chip design)